Growing community of inventors

Thousand Oaks, CA, United States of America

Chun Li

Average Co-Inventor Count = 6.70

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 82

Chun LiYves Girard (3 patents)Chun LiRichard W Friesen (3 patents)Chun LiLaird A Trimble (2 patents)Chun LiNathalie Chauret (2 patents)Chun LiDaniel Guay (1 patent)Chun LiDaniel Dube (1 patent)Chun LiYves Ducharme (1 patent)Chun LiPierre A Hamel (1 patent)Chun LiRichard Frenette (1 patent)Chun LiMichel Gallant (1 patent)Chun LiMarc Labelle (1 patent)Chun LiMichel L Belley (1 patent)Chun LiMarc Blouin (1 patent)Chun LiSebastien Laliberte (1 patent)Chun LiMario Girard (1 patent)Chun LiNicholas Lachance (1 patent)Chun LiAnnette Robichoud (1 patent)Chun LiYvbes Ducharme (1 patent)Chun LiChun Li (4 patents)Yves GirardYves Girard (48 patents)Richard W FriesenRichard W Friesen (27 patents)Laird A TrimbleLaird A Trimble (5 patents)Nathalie ChauretNathalie Chauret (3 patents)Daniel GuayDaniel Guay (35 patents)Daniel DubeDaniel Dube (30 patents)Yves DucharmeYves Ducharme (29 patents)Pierre A HamelPierre A Hamel (28 patents)Richard FrenetteRichard Frenette (27 patents)Michel GallantMichel Gallant (27 patents)Marc LabelleMarc Labelle (26 patents)Michel L BelleyMichel L Belley (26 patents)Marc BlouinMarc Blouin (12 patents)Sebastien LaliberteSebastien Laliberte (10 patents)Mario GirardMario Girard (9 patents)Nicholas LachanceNicholas Lachance (2 patents)Annette RobichoudAnnette Robichoud (1 patent)Yvbes DucharmeYvbes Ducharme (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merck Frosst Canada & Co. (4 from 76 patents)


4 patents:

1. 6677351 - 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors

2. 6448274 - Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor

3. 6211197 - Prostaglandin receptor ligands

4. 6204275 - PDE IV inhibiting compounds, compositions and methods of treatment

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…